Atlas Trials

Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC

Clinical trial NCT05775419 · RECRUITING

Trial details

NCT number
NCT05775419
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal Squamous Cell CarcinomaChemotherapy EffectSide Effect of Drug
Start date
2021-06-30
Primary completion
2025-06-30
Enrollment
1216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.